Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07674680 · ClinicalTrials.gov registry record · Early Phase 1
Beta3-adrenergic Receptors and Cardiovascular Function in Aging Women
A Early Phase 1 study, sponsored by University of Missouri-Columbia.
- Not yet
- Registry status
- Early Phase 1
- Development phase
- 60
- Enrollment target
NCT07674680: Clinical Trial Early Phase 1 study, sponsored by University of Missouri-Columbia.
NCT07674680 is a Early Phase 1 study that has not yet begun recruiting, run by University of Missouri-Columbia. The registered enrollment target is 60 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (13% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07674680, a Early Phase 1 study, has not yet begun recruiting, sponsored by University of Missouri-Columbia.
- NOT YET RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
We hypothesize vascular beta3 adrenergic receptors are present and functional in aging women and can be targeted to attenuate sympathetic vasoconstriction and enhance vascular function in aging women.
Primary Outcome
Blood flow measured with Doppler ultrasound.
Interventions
- DRUG Placebo
- DRUG Gemtesa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-07 |
| Est. Completion | 2029-05 |
| Phase | Early Phase 1 |
What is known before NCT07674680 opens enrollment
NCT07674680 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (13% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07674680 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07674680 about?
NCT07674680 is a clinical study titled "Beta3-adrenergic Receptors and Cardiovascular Function in Aging Women". We hypothesize vascular beta3 adrenergic receptors are present and functional in aging women and can be targeted to attenuate sympathetic vasoconstriction and enhance vascular function in aging women.
What is the current status of trial NCT07674680?
This trial is currently not yet recruiting. It is a Early Phase 1 study. The enrollment target is 60 participants. The study started on 2026-07. Estimated completion is 2029-05.
What interventions are being tested in trial NCT07674680?
The interventions under investigation include: Placebo (DRUG), Gemtesa (DRUG).
Who is sponsoring clinical trial NCT07674680?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07674680's enrollment target sits among peer trials
60 403rd of 2000 higher than 1,564 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia